Simple supplement may slow vision loss in rare eye disease
Disease control
Not yet recruiting
This phase 3 trial tests whether taking serine, a natural amino acid, twice a day can slow vision loss in people with MacTel type 2, a rare eye disease. About 120 participants will receive either serine or a placebo for 24 months, with regular eye exams and imaging. The study aim…
Phase: PHASE3 • Sponsor: The Lowy Medical Research Institute Limited • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC